| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 04/02/2013 | US8410274 Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 04/02/2013 | US8410134 8-oxy-quinoline derivatives as bradykinin B2 receptor modulators |
| 04/02/2013 | US8410119 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 04/02/2013 | CA2701912C Method for the preparation of montelukast acid in ionic liquid medium |
| 04/02/2013 | CA2642130C Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors |
| 04/02/2013 | CA2543248C Process for making sterile aripiprazole of desired mean particle size |
| 03/28/2013 | WO2013041407A1 Hydroxamic acids as hdac6 inhibitors |
| 03/28/2013 | WO2013040801A1 Hydroxamic acid compound containing quinolyl and preparation method thereof, and pharmaceutical composition containing this compound and use thereof |
| 03/28/2013 | US20130079524 Fungicide n-cycloalkyl-n-bicyclic-carboxamide derivatives |
| 03/28/2013 | US20130079367 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 03/28/2013 | US20130076604 Novel organic compound and organic light-emitting device including the same |
| 03/28/2013 | CA2858033A1 Quinolyl-containing hydroxamic acid compound and preparation method thereof, and pharmaceutical composition containing this compound and use thereof |
| 03/27/2013 | EP2573559A1 Modulation of chemosensory receptors and ligands associated |
| 03/27/2013 | EP2571853A1 Inhibitors of human 12-lipoxygenase |
| 03/27/2013 | EP2571352A1 Selective hdac inhibitors |
| 03/27/2013 | CN1681791B 8-羟基喹啉衍生物 8-hydroxyquinoline derivative |
| 03/27/2013 | CN102993094A Synthesizing method of tetrahydroquinoline derivative |
| 03/27/2013 | CN102993084A Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 03/27/2013 | CN102992942A Organic compound and organic light emitting device having the same |
| 03/27/2013 | CN102153512B Preparation method of rebamipide intermediate |
| 03/27/2013 | CN101146786B Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 03/26/2013 | US8404849 Processes for producing modulators of cystic fibrosis transmembrane conductance regulator |
| 03/26/2013 | US8404713 Quinolinone derivatives as PARP inhibitors |
| 03/21/2013 | WO2013039428A2 Quinoline derivatives, in particular 5,6,7-substituted 1-(2-chloroquinolin-3-yl)- 4-dimethylamino-2-(naphthalen-1-yl)-1-phenylbutan-2-ols, method for producing same and use of said compounds |
| 03/21/2013 | WO2013039187A1 Guanidinobenzoic acid compound |
| 03/21/2013 | WO2013038944A1 Light-emitting element material and light-emitting element |
| 03/21/2013 | WO2013037838A1 Polymorphic form of pitavastatin calcium |
| 03/21/2013 | US20130072688 Method for preparing an intermediate of pitavastatin or of the salt thereof |
| 03/21/2013 | US20130072522 Process for Making Modulators of Cystic Fibrosis Transmembrane Conductance Regulator |
| 03/21/2013 | US20130072520 Antibacterial agents |
| 03/21/2013 | CA2848561A1 Guanidinobenzoic acid compound |
| 03/20/2013 | EP2570403A1 Urea compounds and use thereof for inhibiting apoptosis |
| 03/20/2013 | EP2569285A1 Bifunctional quinoline derivatives |
| 03/20/2013 | CN102985407A 8-hydroxy-quinoline derivatives |
| 03/20/2013 | CN102977014A New quinoline compounds and uses thereof |
| 03/20/2013 | CN101638353B Method for removing residual metal in organic compounds by using EDTA calcium disodium salts as chelons in liquid phase |
| 03/19/2013 | US8399675 Compounds and preparation for montelukast sodium |
| 03/19/2013 | US8399674 Quinolines |
| 03/19/2013 | US8399673 Substituted 2-mercaptoquinoline-3-carboxamides as KCNQ2/3 modulators |
| 03/19/2013 | US8399469 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 03/19/2013 | US8399447 Metal triangulo compound and methods of using the same |
| 03/19/2013 | CA2538960C Cinnamoyl compound and use of the same |
| 03/14/2013 | US20130065963 Histone Deacetylase Inhibitors and Methods of Use Thereof |
| 03/14/2013 | US20130065922 Novel amides as fungicides |
| 03/13/2013 | EP2567955A2 Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
| 03/13/2013 | EP2567954A1 Method for inhibiting tau protein aggregation and treatment of alzheimer's disease with a compound derived from quinoline |
| 03/13/2013 | EP2566849A1 8-hydroxy-quinoline derivatives |
| 03/13/2013 | EP2566477A1 Amino-quinolines as kinase inhibitors |
| 03/13/2013 | CN102971297A Method for preparing an intermediate of pitavastatin or of the salt thereof |
| 03/13/2013 | CN102964301A Method for synthesizing IOX2 |
| 03/13/2013 | CN102964300A Synthetic method of 2-(3'-quinolinyl) allyl alcohol compound |
| 03/13/2013 | CN102267950B Oxime ether dichloro-allyl ether compounds with insecticidal activity |
| 03/13/2013 | CN101910135B Quinoline derivatives and their use as fungicides |
| 03/12/2013 | US8394986 Phenoxiacetic acid derivatives |
| 03/12/2013 | US8394959 Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-2-buteramide and crystalline forms thereof |
| 03/12/2013 | US8394958 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1H-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents |
| 03/12/2013 | US8394829 Bi-functional quinoline analogs |
| 03/12/2013 | US8394828 Quinoline-derived amide modulators of vanilloid VR1 receptor |
| 03/12/2013 | US8394827 Inhibitor of the differentiation of T cells into Th1 cells |
| 03/12/2013 | US8394826 Dual mechanism inhibitors for the treatment of disease |
| 03/12/2013 | US8394821 Activated blood coagulation factor inhibitor |
| 03/12/2013 | US8394794 Therapeutic compounds |
| 03/12/2013 | CA2623507C Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration |
| 03/12/2013 | CA2551227C Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies |
| 03/12/2013 | CA2531661C Histone deacetylase inhibitors and methods of use thereof |
| 03/07/2013 | WO2013033269A1 Bioorthogonal monomers capable of dimerizing and targeting bromodomains and methods of using same |
| 03/07/2013 | WO2013032273A2 Quinolinium single crystals for use in nonlinear optics |
| 03/07/2013 | WO2013029548A1 Quinolone compound |
| 03/07/2013 | WO2013029079A1 Olefin metathesis |
| 03/07/2013 | WO2012168213A3 Novel process for the synthesis of 7-chloro-4-(piperazin-1-yl)-quinoline |
| 03/07/2013 | WO2012140490A3 Processes for preparing pitavastatin calcium |
| 03/07/2013 | US20130059885 Method For Preparation Of Pitavastatin and Pharmaceutical Acceptable Salts Thereof |
| 03/07/2013 | US20130059852 Compounds for treating disease, for administering, and for pharmaceutical compositions |
| 03/07/2013 | CA2845459A1 Quinolone compound |
| 03/06/2013 | EP2563761A1 Activators of human pyruvate kinase |
| 03/06/2013 | CN102958919A Novel tetrahydroquinoline derivatives |
| 03/06/2013 | CN102958918A Novel nicotinamide derivatives or salts thereof |
| 03/06/2013 | CN102958906A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 03/06/2013 | CN102952070A Trifluoromethyl-substituted quinoline ring contained ether compound and its use |
| 03/06/2013 | CN102952062A Substituted benzoheterocyclic compounds and preparation method and application thereof |
| 03/06/2013 | CN101679359B Quinolines and their therapeutic use |
| 03/05/2013 | US8389730 Compositions and methods for the treatment of disease associated with TRP-P8 expression |
| 03/05/2013 | US8389729 Methods for detecting the presence, location or quantity of targets using novel dyes |
| 03/05/2013 | US8389728 Pollen tube stimulants from Arabidopsis pistils |
| 03/05/2013 | US8389727 Solid forms of N-(4-(7-Azabicyclo[2.2.1]Heptan-7-yl)-2-Trifluoromethyl)Phenyl)-4-Oxo-5-(Trifluoromethyl)-1,4-Dihydroquinoline-3-Carboxamide |
| 03/05/2013 | US8389570 Hydroxamates as therapeutic agents |
| 03/05/2013 | US8389545 Quinolone M1 receptor positive allosteric modulators |
| 02/28/2013 | WO2013028132A1 Chiral phosphines for palladium-catalyzed asymmetric alpha-arylation of ester enolates to produce tertiary stereocenters in high enantioselectivity |
| 02/28/2013 | WO2013027510A1 Organic electroluminescence element and lighting system |
| 02/28/2013 | WO2013027168A1 Novel heterocyclic compounds as bromodomain inhibitors |
| 02/28/2013 | US20130053413 Crystalline forms of pitavastatin calcium |
| 02/28/2013 | US20130053404 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation |
| 02/28/2013 | US20130053375 Amino-quinolines as kinase inhibitors |
| 02/28/2013 | US20130053359 NEW CYCLOHEXYLAMINE DERIVATIVES HAVING beta2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES |
| 02/28/2013 | US20130053333 Aminoquinoline Derivatives |
| 02/27/2013 | EP2562157A1 Heteroaryl (alkyl) dithiocarbamate compounds, preparation methods and uses thereof |
| 02/27/2013 | EP2560652A2 Anti-viral compounds |
| 02/27/2013 | CN102947285A Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| 02/27/2013 | CN102946881A Anti-viral compounds |
| 02/27/2013 | CN102946741A Organic compounds |